Related Experiment Video
Updated: Jul 2, 2026
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Increased level of platelet microparticles in survivors of myocardial infarction
Annika E Michelsen1, Ellen Brodin, Frank Brosstad
1Research Institute for Internal Medicine, University of Oslo, Oslo, Norway.
Abstract:
Platelet microparticles (PMPs) are highly procoagulant and might therefore be important in the pathogenesis of arterial thrombotic diseases. The aim of this study was to determine plasma levels of PMPs in survivors of myocardial infarction (MI) and their relation to activation of primary (sCD40L) and secondary (thrombin-antithrombin (TAT) complexes) haemostasis. An observational, population-based case control study was conducted in 61 MI patients 1-4 years after the MI and 61 age-matched and sex-matched healthy controls. PMPs were quantified using an immunoassay that discriminates between small and large PMPs. MI patients had significantly higher total PMPs (314.3 microg/L, 273.1-361.4 microg/L versus 225.8 microg/L, 168.8-273.1 microg/L, p=0.009) (geometric mean and 95% CI) and larger PMPs (181.3 microg/L, 160.7-204.3 microg/L versus 134.3 microg/L, 104.6-174.9 microg/L) than controls. The differences between groups remained significant after adjustments for use of cardiovascular drugs, body mass index, blood pressure and serum lipids, but were weakened when smoking was included in the analysis. Multiple regression analysis revealed a significant independent association between large PMPs and plasma TAT and soluble CD40 ligand (sCD40L) in MI patients, but not in healthy controls. The independent association between large PMPs and thrombin generation supports the concept that formation of PMPs is important for increased coagulation activation in MI patients.
Insights
Platelet microparticles (PMPs) are elevated in myocardial infarction (MI) survivors, indicating increased coagulation activation. Larger PMPs are independently associated with thrombin generation and soluble CD40 ligand in MI patients.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Thrombosis Research
Background:
- Platelet microparticles (PMPs) possess procoagulant properties, suggesting a role in arterial thrombotic diseases.
- Understanding PMP levels in myocardial infarction (MI) survivors is crucial for elucidating thrombotic mechanisms.
Purpose of the Study:
- To quantify plasma levels of Platelet Microparticles (PMPs) in myocardial infarction (MI) survivors.
- To investigate the relationship between PMP levels and markers of primary (sCD40L) and secondary (thrombin-antithrombin complexes) hemostasis.
Main Methods:
- An observational, population-based case-control study involving 61 MI survivors and 61 matched healthy controls.
- Quantification of small and large PMPs using a specific immunoassay.
- Multiple regression analysis to assess associations between PMPs, hemostatic markers, and clinical factors.
Main Results:
- MI survivors exhibited significantly higher total and large PMP levels compared to controls.
- Elevated PMP levels persisted after adjusting for cardiovascular risk factors and medications.
- Large PMPs showed a significant independent association with thrombin-antithrombin complexes and soluble CD40 ligand in MI patients.
Conclusions:
- Increased formation of Platelet Microparticles is linked to heightened coagulation activation in myocardial infarction survivors.
- PMP levels, particularly larger ones, serve as potential biomarkers for thrombotic risk post-MI.
Related Concept Videos
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...